A PROSPECTIVE EVALUATION OF HEPATIC, SYSTEMIC AND PULMONARY HEMODYNAMICS IN HIV-HCV COINFECTED PATIENTS PRIOR AND AFTER ANTIVIRAL THERAPY

被引：0
|
作者：
Reiberger, T. [1 ]
Ferlitsch, A. [1 ]
Payer, B. A. [1 ]
Sieghart, W. [1 ]
Rieger, A. [2 ]
Peck-Radosavljevic, M. [1 ]
机构：
[1] Med Univ Vienna, Div Gastroenterol Hepatol, Vienna, Austria
[2] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Vienna, Austria
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61178-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1176
引用
收藏
页码：S464 / S465
页数：2
相关论文
共 50 条
  • [1] A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin
    Reiberger, Thomas
    Payer, Berit A.
    Ferlitsch, Arnulf
    Sieghart, Wolfgang
    Breitenecker, Florian
    Aichelburg, Maximilian C.
    Schmied, Brigitte
    Rieger, Armin
    Trauner, Michael
    Peck-Radosavljevic, Markus
    ANTIVIRAL THERAPY, 2012, 17 (07) : 1327 - 1334
  • [2] Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients
    Monto, Alexander
    Kakar, Sanjay
    Dove, Lorna M.
    Bostrom, Alan
    Miller, Erica L.
    Wright, Teresa L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1509 - 1515
  • [3] A Prospective Study of The Association of Body Morphometry With Hepatic Steatosis and Fibrosis in HIV-HCV Coinfected Patients
    Awad, Chadi M.
    Nguyen, Tuyet A.
    Puri, Puneet
    Sanyal, Arun J.
    Luketic, Velimir A.
    Stravitz, R. Todd
    Siddique, Mohammad S.
    Bouneva, Iliana
    Sterling, Richard K.
    HEPATOLOGY, 2013, 58 : 1305A - 1306A
  • [4] Effects of Antiviral Therapy on Liver Histology, Hvpg and Liver Stiffness in HIV-HCV Coinfected Patients
    Reiberger, Thomas
    Ferlitsch, Arnulf
    Payer, Berit A.
    Sieghart, Wolfgang
    Rieger, Armin
    Peck-Radosavljevic, Markus
    GASTROENTEROLOGY, 2010, 138 (05) : S829 - S829
  • [5] The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV
    Payer, B. A.
    Reiberger, T.
    Breitenecker, F.
    Aichelburg, M. C.
    Schuster, C.
    Heil, P. M.
    Scherzer, T. M.
    Ferenci, P.
    Rieger, A.
    Peck-Radosavljevic, M.
    JOURNAL OF INFECTION, 2012, 65 (02) : 142 - 149
  • [6] Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors
    Bani-Sadr, F
    Carrat, F
    Bedossa, P
    Piroth, L
    Cacoub, P
    Perronne, C
    Degott, C
    Pol, S
    AIDS, 2006, 20 (04) : 525 - 531
  • [7] Aggressive daily interferon therapy in HIV-HCV coinfected patients
    Bruno, R
    Sacchi, P
    Filice, C
    Filice, G
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (04) : 372 - 373
  • [8] Diagnosis of hepatic fibrosis and cirrhosis by liver stiffness measurement in HIV-HCV coinfected patients: A prospective study
    de Ledinghen, V
    Douvin, C
    Kettaneh, A
    Ziol, M
    Roulot, D
    Marcellin, P
    Dhumeaux, D
    Beaugrand, M
    HEPATOLOGY, 2005, 42 (04) : 445A - 445A
  • [9] Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV-HCV Coinfected Patients
    Tripathi, Gaurav
    Rooge, Sheetalnath
    Yadav, Manisha
    Mathew, Babu
    Sharma, Nupur
    Bindal, Vasundhra
    Hemati, Hamed
    Singh Maras, Jaswinder
    Gupta, Ekta
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [10] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
12345